Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy
about
Progress toward in vivo use of siRNAs-IIMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesMolecular imaging of the tumor microenvironment for precision medicine and theranostics.PSMA-targeted theranostic nanoplex for prostate cancer therapy.Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.Choline metabolism in malignant transformation.High-field small animal magnetic resonance oncology studies.Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein.Recent advances in nonviral vectors for gene delivery.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.Magnetic Resonance Spectroscopy of siRNA-Based Cancer TherapyMR - eyes for cancer: looking within an impenetrable diseaseDegradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy.In vivo imaging of the systemic delivery of small interfering RNA.Multimodality imaging of RNA interferenceTumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.Nanomedicine for gene therapy.Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging.Imaging-guided delivery of RNAi for anticancer treatment.PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.Oligonucleotide-based theranostic nanoparticles in cancer therapy.Magnetic Resonance Imaging and Spectroscopy in Cancer Theranostic Imaging.Targeting Phospholipid Metabolism in Cancer.A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect.Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage.Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation.Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.
P2860
Q28255877-A4435D64-3565-4170-8805-6869414BADD4Q30354223-CD92EEDB-B093-4FEE-9F9C-FDE2C2524A58Q30367515-2D0AC3C5-9838-486B-A557-52D3DE8036FCQ33791366-6DF6842E-BE05-4215-A40B-268940C9B5A3Q35064453-2264CE73-E476-479E-82EE-78AF211C98F7Q35112040-DEAE1D1B-F627-4323-A8EE-DED9CA6EB73EQ35312455-5FF24263-982C-4E54-931C-8FE2FAD72F59Q35537301-9D31CBC7-4682-4EB1-9788-A9F92753DBD6Q35618915-AC514ABE-4B01-4D1E-8BE9-268610E77149Q35625854-AD867769-8B06-4F47-9CB2-40E1E18D3E57Q36910668-560D9FA4-44CE-47F2-A512-15A9D19E15E3Q36949372-9D8280AE-15E9-4BE3-9276-6BF2384176F7Q37636194-7E8D3728-E9B0-4F7E-BDE3-46C8E4BD067DQ37974175-87D2344C-E248-45C6-90C4-B8D56018187DQ38112726-9A5924C8-AD01-4133-9893-E30ADB294931Q38191832-2AD88FFF-6F73-4BDF-8570-DF4B3FFFDA45Q38383478-DBF9EF6F-B2F6-4099-874A-10B046071641Q38657755-49627136-F6FF-4462-8771-218F8886B402Q38710046-0F855481-041E-4765-B700-70FC603E8216Q38808957-DA8B8CD2-AD97-4113-9C52-CCEB224A2479Q38814327-DCB81E8E-C315-4518-868A-311B4DA9C7C1Q38982546-8DC8D945-33DC-40D3-8741-7A9B55CB08ADQ39084885-E1E70F68-1B07-4E83-B3CA-0F36B9AB0F23Q39161466-C7EC85BE-B927-49FD-A0E7-4A939A43535CQ40262447-2FE1B328-9907-4B3F-ABB3-B419C67039C2Q47106820-C5C7C3A7-C617-46E6-AA0A-9BEEF1640CE7Q49207200-54413993-5D7E-4406-A71E-F166A5012DCC
P2860
Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@ast
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@en
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@nl
type
label
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@ast
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@en
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@nl
prefLabel
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@ast
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@en
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@nl
P2093
P2860
P356
P1433
P1476
Nanoplex delivery of siRNA and ...... athway targeted cancer therapy
@en
P2093
Dmitri Artemov
Flonné Wildes
Marie-France Penet
Paul T Winnard
Tomoyo Takagi
Zaver M Bhujwalla
P2860
P304
P356
10.1021/NN102187V
P407
P50
P577
2010-10-19T00:00:00Z